cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
- RxCUI
- 2184142
- RxNorm name
- cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
- Display name
- cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
- Full name
- cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RECARBRIO | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | Merck Sharp & Dohme LLC | be32f468-738b-40df-a425-591e12f65159 | 2025-12-09 | Warnings, Adverse reactions | 2184142 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| be32f468-738b-40df-a425-591e12f65159 | cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection [PSN] · cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection [SCD] | 2 | 11 | These highlights do not include all the information needed to use RECARBRIO safely and effectively. See full prescribing information for RECARBRIO. RECARBRIO ® (imipenem, cilastatin, and relebactam) for injection, for intravenous use Initial U.S. Approval: 2019 | 20251209 |